September 05.2010
CTQJPH
CHINESE
Home
|
About Us
|
Products
|
New & Support
|
International Trade
|
Contact Us
Pharmaceutical Intermediates
Pharmaceutical Intermediates
Capecitabine intermediate K4
Capecitabine Intermediate K45
Gemcitabine HCl intermediateT3
Gemcitabine HCl intermediateT6
Gemcitabine HCl intermediateT8
Gemcitabine HCl IntermediateT9
Febuxostat Intermediate T1
Febuxostat Intermediate T2
Febuxostat Intermediate T3
Febuxostat Intermediate T4
Febuxostat Intermediate T5
APIs
APIs
Capecitabine
Gemcitabine Hydrochloride
Risedronate Sodium
Altretamine
Febuxostat
Allicin Oil
Finished Dosage
Cefixime Tablets
Cefaclor Tablets
Cefaclor Suspension
Cefaclor and Bromhexine Hydroc
Cefaclor and Bromhexine Hydroc
Terramycin Tablets
Meleucamycin Tablets
Glucosamine Hydrochloride Tabl
Altretamine Capsule
Home > New & Support
Welcome to our CPHI Booth in Shanghai
Link:
http://www.ctqjpharm.com/newsview-174
Information of Febuxostat
Link:
http://www.ctqjpharm.com/newsview-173
Indications and Important Safety Information for gemcitabine for injection
Link:
http://www.ctqjpharm.com/newsview-172
The 6th Annual Japan DIA Meeting, Oct 22 2009 8:00AM - Oct 23 2009 5:00PM
Link:
http://www.ctqjpharm.com/newsview-169
4th Annual Conference on Drug Discovery and Clinical Development in India: Scientific and Regulatory Advances Across Borders, Nov 15 2009 8:00AM - Nov 18 2009 5:00PM
Link:
http://www.ctqjpharm.com/newsview-162
[1]
[2]
Home
|
FAQ
Copyright © 2008 JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO.,LTD. All rights reserved.
Tel: 086-025-68551657 Fax: 086-025-68551658 E-Mail: cphi@ctqjpharm.com
